BlackRock Stock Rally Is Unsustainable

After gaining more than 100% since the March 23 lows of this year, at the current price of around $710 per share we believe BlackRock stock (NYSE: BLK) has achieved its near-term potential. BlackRock, the world’s largest asset manager, has seen its stock increase from $327 to $710 off the recent bottom compared to the S&P 500 which increased almost 65%. The stock is leading the broader markets by a huge margin and is up 41% YTD. This could be attributed to better than expected results in each of the last 3 quarters mainly driven by the recovery in global financial markets which improved the asset valuations and attracted more funds. Further, BlackRock revenues have grown 11% to a consolidated figure of $11.73 billion for the last 3 quarters from the consolidated figure of $10.56 billion for the year-ago period.


While BLK revenue growth was slow over 2018-2019, its P/E multiple has increased. We believe the stock has reached its near term potential and is unlikely to see much upside after the recent rally and potential weakness from a recession-driven by the Covid outbreak. Our dashboard Why BlackRock Stock Moved 78% Between 2018-End And Now? provides the key numbers behind our thinking.

BlackRock’s revenues increased 2% over 2018-2019, which translated into a 4% gain in net income figures over the same period. This led to an increase in the EPS figure from $26.86 to $28.69.

During the same period, the P/E multiple increased from just below 15x to close to 18x. The multiple further increased in 2020 as the company has outperformed earnings estimates over the last three quarters. While the company’s P/E is just above 25x now, there is a potential downside when the current P/E is compared to levels seen in the past years – P/E of close to 18x at end of 2019 and 17x at the end of 2017.

Where Is The Stock Headed?

BlackRock nine months cumulative revenues for 2020 have increased by 11% y-o-y, while its stock is up 38% YTD. Although the positive revenue growth did help in shaping a favorable investor sentiment toward BlackRock, it was also due to headwinds in other industries like travel, hospitality, energy, real estate, automotive, etc., which made the stock a better investment opportunity for investors. However, with Pfizer PFE and Moderna’s Covid-19 vaccines receiving emergency FDA approval, it is likely to divert investor money back to other industries. Overall, the BlackRock stock is unlikely to see significant upside in the near term.


The actual recovery and its timing hinge on the broader containment of the coronavirus spread. Our dashboard Trends In U.S. Covid-19 Cases provides an overview of how the pandemic has been spreading in the U.S. and contrasts with trends in Brazil and Russia. Following the Fed stimulus — which set a floor on fear — the market has been willing to “look through” the current weak period and take a longer-term view. With investors focusing their attention on 2021 results, the valuations become important in finding value. Though market sentiment can be fickle, and evidence of an uptick in new cases could spook investors once again.

What if you’re looking for a more balanced portfolio instead? Here’s ahigh quality portfolio to beat the market, with over 100% return since 2016, versus 55% for the S&P 500. Comprised of companies with strong revenue growth, healthy profits, lots of cash, and low risk, it has outperformed the broader market year after year, consistently.


See all Trefis Price Estimates and Download Trefis Data here

What’s behind Trefis? See How It’s Powering New Collaboration and What-Ifs For CFOs and Finance TeamsProduct, R&D, and Marketing Teams

Comments are closed.